Female Stress Urinary Incontinence
Conditions
Keywords
female, stress urinary incontinence, treatment, pelvic floor muscle training, smartphone, internet, life style, eHealth
Brief summary
The purpose of this study is to determine whether treatment of stress urinary incontinence (SUI) via smartphone is effective.
Detailed description
Female urinary incontinence (UI) is very common and affects up to one fourth of grownup women. It may reduce quality of life for those affected and costs for society are high. The most common type of urinary incontinence is SUI, i.e leakage when coughing, sneezing or jumping. The recommended first line treatment is pelvic floor muscle training (PFMT)which leads to improvement or cure in two-thirds of patients. In addition, life style changes, such as weight loss when obese, smoking cessation and reduction of fluid intake if high is recommended. There is a need for new , flexible and easily accessible treatment programmes for female urinary incontinence. In our previous study, we compared two treatment programmes for SUI without face-to-face contact: one internet based and one sent by post, both based on three months of PFMT. In this randomized controlled trial of 250 women aged 18-70 years, we found highly significant improvements (p\<0.001) with large effect sizes (\>0,8)concerning primary outcomes (symptoms and quality of life scores) but no significant differences between groups. Compared with the postal group, more participants in the internet group perceived they were much or very much improved (40.9% vs 26.5%, p\<0.01, reported reduced usage of incontinence aids (59.5% vs 41.4%, p=0.02) and were satisfied with the treatment programme (84.8% vs 62.9%, p\<0.001). The selling of smartphones is increasing rapidly. About 75% of all cellphones sold in Sweden today are smartphones. Two million adults in Sweden have a smartphone. Many smartphone owners have at least one health app on their phone. Exercise, diet, and weight apps are the most popular types. From our previous experience of an Internet-based programme, we have developed a treatment program designed for smartphone. The effect of the treatment programme will be evaluated after three months by comparing the effect in the smartphone group with the effect in the waiting group. Participants are consecutively recruited through our website. They answer an online screening survey with automated immediated response for initial screening of eligibility criteria. Informed consent and leakage diary (number of episodes of urinary leakage during 48 hours) are sent by post. After that, they answer a web questionnaire and finally they are interviewed by a researcher to confirm the diagnosis SUI and to ascertain that the patient is well informed of the study procedure. Women are then randomized to either of the two groups. Women in the smartphone group get a smartphone application for iphone or android. Follow-up after three months with a web questionnaire and a leakage diary. After that the waiting group get their smartphone application. We aim to recruit 120 women aged 18 and older via our website www.tät.nu. In the power calculation we assume that the improvement in the symptom score (ICIQ UI SF) and the QOL score (ICIQ luts QOL)in the smartphone group will be similar to the improvement we found in the postal group in our previous study. We also assume that the waiting group will improve in some extent. To detect a difference between groups, power 80%, 2-side test and significance 0,05, group size as follow ICIQ UI SF Smartphone group improves 2.9 (SD3,1) and waiting group 1,0 (SD2,0); 30 in each group ICIQ luts QOL Smartphone group improves 4.6 (SD6,7) and waiting group 2.0(SD3.0), 35 in each group PGI (patient´s global impression of improvement). 26,5% improves much or very much (smartphone) and 4% (waiting group):39 in each group We expect a drop out rate of 33% and thus need approximately 120 persons, 60 in each group.
Interventions
A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. The treatment period is three months
Sponsors
Study design
Eligibility
Inclusion criteria
* stress urinary incontinence * leakage once a week or more often * duration of symptoms for at least 6 months * motivation and time to perform a 12 week long treatment with pelvic floor muscle training * ability to read and write Swedish * asset to smartphone * possibility to send and receive email and asset to printer * accept to be randomized to one of two groups; a treatment group or a waiting list group
Exclusion criteria
* participation in our previous internet study * pregnancy * former incontinence surgery * known malignancy in lower abdomen * difficulties with passing urine * visual blood in urine * intermenstrual bleeding * severe psychiatric diagnosis * neurological disease with affection on sensibility in legs or lower abdomen * urge incontinence
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| International Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF) | baseline, three months | Three items on frequency, amount of leakage and overall impact. Scoring 0-21, higher values indicating increasing severity |
| International Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol) | baseline, three months | The instrument includes 19 items on the impact of the leakage. All items are scored 1-4 (not at all/never, slightly/sometimes, moderately/often, a lot/all the time). The overall score is 19-76, with higher values indicating increased impact on QOL. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Usage of Incontinence Aids | three months | Usage of incontinence aids during the last 4 weeks. |
| Patient Satisfaction | three months | A self-rated question about if the current treatment was sufficient, with three response options |
| Incontinence Episode Frequency (IEF) | baseline, three months | number of incontinence episodes per week |
| Patient's Global Impression of Improvement Scale (PGI-I) | three months | A self-rated question that asks about the change experienced after treatment with 7 response options, ranging from very much better to very much worse. |
Countries
Sweden
Participant flow
Recruitment details
We recruited community-dwelling women, from March 2013 to October 2014, through our website. Interested women filled out a questionnaire to determine whether they met the study criteria. Eligible women received a letter with informed consent and a 2-day leakage diary, and after returning this they also answered a web-based questionnaire.
Pre-assignment details
Randomisation was performed by concealing the allocations in sequentially numbered, opaque, sealed envelopes. An independent administrator generated the allocation sequence and prepared 130 envelopes. The study coordinator opened one envelope for each participant and assigned an e-mail, with materials for the corresponding study group.
Participants by arm
| Arm | Count |
|---|---|
| Smartphone Treatment Smartphone treatment with pelvic floor muscle training (PFMT).
Smartphone treatment with PFMT: A smartphone application with information on SUI, life style information, different programmes of PFMT with increasing severity, possibility to save statistics on training. Possibility to set reminders. The treatment period is three months | 62 |
| Waiting List Waiting list for three months. They receive the smartphone application after follow-up. | 61 |
| Total | 123 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Lost to Follow-up | 1 | 1 |
Baseline characteristics
| Characteristic | Smartphone Treatment | Waiting List | Total |
|---|---|---|---|
| Age, Continuous | 44.8 years STANDARD_DEVIATION 9.7 | 44.7 years STANDARD_DEVIATION 9.1 | 44.7 years STANDARD_DEVIATION 9.4 |
| Body Mass Index | 24.0 kg/m^2 STANDARD_DEVIATION 4.1 | 24.5 kg/m^2 STANDARD_DEVIATION 4.4 | 24.2 kg/m^2 STANDARD_DEVIATION 4.2 |
| Education <3 years at university level | 10 participants | 15 participants | 25 participants |
| Education >=3 years at university level | 52 participants | 46 participants | 98 participants |
| Parity not nulliparous | 57 participants | 57 participants | 114 participants |
| Parity nulliparous | 5 participants | 4 participants | 9 participants |
| Region of Enrollment Sweden | 62 Participants | 61 Participants | 123 Participants |
| Regular Medication no regular medication | 34 participants | 37 participants | 71 participants |
| Regular Medication on regular medication | 28 participants | 24 participants | 52 participants |
| Sex: Female, Male Female | 62 Participants | 61 Participants | 123 Participants |
| Sex: Female, Male Male | 0 Participants | 0 Participants | 0 Participants |
| Smoking non-smoker | 60 participants | 58 participants | 118 participants |
| Smoking smoker | 2 participants | 3 participants | 5 participants |
| Usage of incontinence aids 1-3 times/week | 19 participants | 18 participants | 37 participants |
| Usage of incontinence aids 1 aid a day | 9 participants | 10 participants | 19 participants |
| Usage of incontinence aids >3 times/week, but not daily | 11 participants | 5 participants | 16 participants |
| Usage of incontinence aids Less than once a week | 13 participants | 14 participants | 27 participants |
| Usage of incontinence aids More than 1 aid a day | 4 participants | 4 participants | 8 participants |
| Usage of incontinence aids No use | 6 participants | 10 participants | 16 participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — |
| other Total, other adverse events | 0 / 62 | 0 / 61 |
| serious Total, serious adverse events | 0 / 62 | 0 / 61 |
Outcome results
International Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol)
The instrument includes 19 items on the impact of the leakage. All items are scored 1-4 (not at all/never, slightly/sometimes, moderately/often, a lot/all the time). The overall score is 19-76, with higher values indicating increased impact on QOL.
Time frame: baseline, three months
Population: intention-to-treat analysis
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Smartphone Treatment | International Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol) | baseline | 34.1 units on a scale | Standard Deviation 6.1 |
| Smartphone Treatment | International Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol) | 3 month follow-up | 28.8 units on a scale | Standard Deviation 6.4 |
| Waiting List | International Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol) | baseline | 34.8 units on a scale | Standard Deviation 6.1 |
| Waiting List | International Consultation on Incontinence Modular Questionnaire Lower Urinary Tract Symptoms Quality of Life (ICIQ-LUTSqol) | 3 month follow-up | 34.1 units on a scale | Standard Deviation 6.7 |
International Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF)
Three items on frequency, amount of leakage and overall impact. Scoring 0-21, higher values indicating increasing severity
Time frame: baseline, three months
Population: intention-to-treat analysis
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Smartphone Treatment | International Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF) | baseline | 11.1 units on a scale | Standard Deviation 3 |
| Smartphone Treatment | International Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF) | 3 month follow-up | 7.0 units on a scale | Standard Deviation 3.5 |
| Waiting List | International Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF) | baseline | 11.0 units on a scale | Standard Deviation 2.6 |
| Waiting List | International Consultation on Incontinence Modular Questionnaire Urinary Incontinence Short Form (ICIQ-UI SF) | 3 month follow-up | 10.2 units on a scale | Standard Deviation 3.2 |
Incontinence Episode Frequency (IEF)
number of incontinence episodes per week
Time frame: baseline, three months
Population: intention-to-treat analysis. Missing values at follow-up were replaced with the corresponding values at baseline (i.e., no change).
| Arm | Measure | Group | Value (MEDIAN) |
|---|---|---|---|
| Smartphone Treatment | Incontinence Episode Frequency (IEF) | baseline | 21.0 episodes per week |
| Smartphone Treatment | Incontinence Episode Frequency (IEF) | three month follow-up | 7 episodes per week |
| Waiting List | Incontinence Episode Frequency (IEF) | baseline | 17.5 episodes per week |
| Waiting List | Incontinence Episode Frequency (IEF) | three month follow-up | 14 episodes per week |
Patient Satisfaction
A self-rated question about if the current treatment was sufficient, with three response options
Time frame: three months
Population: Data for this outcome measure could only be collected for the smartphone treatment group.
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Smartphone Treatment | Patient Satisfaction | Yes, I am completely free of leakage | 5 participants |
| Smartphone Treatment | Patient Satisfaction | Yes, sufficient, although I am not completely free | 35 participants |
| Smartphone Treatment | Patient Satisfaction | No | 20 participants |
Patient's Global Impression of Improvement Scale (PGI-I)
A self-rated question that asks about the change experienced after treatment with 7 response options, ranging from very much better to very much worse.
Time frame: three months
Population: intention-to-treat analysis. Missing values at follow-up were replaced with a neutral value (i.e., no change).
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Smartphone Treatment | Patient's Global Impression of Improvement Scale (PGI-I) | a little better | 22 participants |
| Smartphone Treatment | Patient's Global Impression of Improvement Scale (PGI-I) | a little worse | 0 participants |
| Smartphone Treatment | Patient's Global Impression of Improvement Scale (PGI-I) | much better | 28 participants |
| Smartphone Treatment | Patient's Global Impression of Improvement Scale (PGI-I) | much worse | 0 participants |
| Smartphone Treatment | Patient's Global Impression of Improvement Scale (PGI-I) | no change | 5 participants |
| Smartphone Treatment | Patient's Global Impression of Improvement Scale (PGI-I) | very much worse | 0 participants |
| Smartphone Treatment | Patient's Global Impression of Improvement Scale (PGI-I) | very much better | 6 participants |
| Waiting List | Patient's Global Impression of Improvement Scale (PGI-I) | very much worse | 0 participants |
| Waiting List | Patient's Global Impression of Improvement Scale (PGI-I) | very much better | 0 participants |
| Waiting List | Patient's Global Impression of Improvement Scale (PGI-I) | much better | 3 participants |
| Waiting List | Patient's Global Impression of Improvement Scale (PGI-I) | a little better | 9 participants |
| Waiting List | Patient's Global Impression of Improvement Scale (PGI-I) | no change | 42 participants |
| Waiting List | Patient's Global Impression of Improvement Scale (PGI-I) | a little worse | 6 participants |
| Waiting List | Patient's Global Impression of Improvement Scale (PGI-I) | much worse | 0 participants |
Usage of Incontinence Aids
Usage of incontinence aids during the last 4 weeks.
Time frame: three months
Population: intention-to-treat analysis. Missing values at follow-up were replaced with the corresponding values at baseline (i.e., no change).
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Smartphone Treatment | Usage of Incontinence Aids | >3 times/week, but not daily | 5 participants |
| Smartphone Treatment | Usage of Incontinence Aids | No use | 23 participants |
| Smartphone Treatment | Usage of Incontinence Aids | Less than once a week | 13 participants |
| Smartphone Treatment | Usage of Incontinence Aids | 1-3 times/week | 10 participants |
| Smartphone Treatment | Usage of Incontinence Aids | 1 aid a day | 8 participants |
| Smartphone Treatment | Usage of Incontinence Aids | More than 1 aid a day | 2 participants |
| Waiting List | Usage of Incontinence Aids | 1 aid a day | 12 participants |
| Waiting List | Usage of Incontinence Aids | >3 times/week, but not daily | 4 participants |
| Waiting List | Usage of Incontinence Aids | 1-3 times/week | 13 participants |
| Waiting List | Usage of Incontinence Aids | No use | 14 participants |
| Waiting List | Usage of Incontinence Aids | More than 1 aid a day | 6 participants |
| Waiting List | Usage of Incontinence Aids | Less than once a week | 11 participants |